{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+of+treatments&page=2", "query": { "intervention": "Combination of treatments", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 12145, "total_pages": 1215, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+of+treatments&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+of+treatments&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T14:21:03.512Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00000696", "title": "A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Interferon alfa-2a", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 48, "start_date": null, "completion_date": "1993-11", "has_results": false, "last_update_posted_date": "2021-11-02", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 6, "location_summary": "Los Angeles, California • Miami, Florida • New Orleans, Louisiana + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000696" }, { "nct_id": "NCT03180853", "title": "Multiple Myeloma Patient Registry", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Myeloma" ], "interventions": [], "intervention_types": [], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2017-05-08", "completion_date": "2018-04-06", "has_results": false, "last_update_posted_date": "2025-02-03", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 69, "location_summary": "Phoenix, Arizona • Fort Smith, Arkansas • Hot Springs, Arkansas + 63 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03180853" }, { "nct_id": "NCT03255096", "title": "A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diffuse Large B-cell Lymphoma", "High-Grade B-cell Lymphoma" ], "interventions": [ { "name": "RO6870810", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2017-08-28", "completion_date": "2019-07-03", "has_results": false, "last_update_posted_date": "2022-01-24", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 4, "location_summary": "Duarte, California • Stanford, California • New York, New York + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03255096" }, { "nct_id": "NCT00003862", "title": "Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastric Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "0 Years to 120 Years" }, "enrollment_count": null, "start_date": "1999-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 55, "location_summary": "Anchorage, Alaska • Phoenix, Arizona • Concord, California + 46 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003862" }, { "nct_id": "NCT00355342", "title": "Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg BID", "type": "DRUG" }, { "name": "DISKUS inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 186, "start_date": "2004-04-28", "completion_date": "2007-09-06", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 37, "location_summary": "Berkeley, California • Fullerton, California • Rancho Mirage, California + 31 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355342" }, { "nct_id": "NCT00903942", "title": "Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer, Stage III" ], "interventions": [ { "name": "radiation therapy", "type": "RADIATION" }, { "name": "Paclitaxel Protein-Bound, and CARBOPLATIN", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2008-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-04-27", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00903942" }, { "nct_id": "NCT03830866", "title": "Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Locally Advanced Cervical Cancer" ], "interventions": [ { "name": "Durvalumab", "type": "BIOLOGICAL" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "external beam radiation therapy (EBRT) + brachytherapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "FEMALE", "summary": "18 Years to 130 Years · Female only" }, "enrollment_count": 770, "start_date": "2019-02-15", "completion_date": "2023-07-03", "has_results": true, "last_update_posted_date": "2024-07-26", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 16, "location_summary": "Phoenix, Arizona • La Jolla, California • Orange, California + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03830866" }, { "nct_id": "NCT03778827", "title": "A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorder", "Autism" ], "interventions": [ { "name": "Intensive Center-Based Pivotal Response Treatment (PRT-C)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "3 Years", "sex": "ALL", "summary": "2 Years to 3 Years" }, "enrollment_count": 75, "start_date": "2019-05-13", "completion_date": "2026-03-28", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03778827" }, { "nct_id": "NCT01109602", "title": "Strength, Flexibility, And Balance Therapy After Stroke", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Yoga focused on strength, flexibility, and balance", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2010-07", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2015-11-23", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01109602" }, { "nct_id": "NCT04371237", "title": "Accelerating Post-exercise Muscle Glycogen Resynthesis in Humans: Impact of Combined Nutrient Intake and Intermittent Pneumatic Compression or Heat Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscle Recovery", "Muscle Soreness", "Glycogen Depletion" ], "interventions": [ { "name": "Compression sleeve", "type": "DEVICE" }, { "name": "Heat therapy", "type": "DEVICE" }, { "name": "Glycogen-depleting exercise session", "type": "OTHER" }, { "name": "Nutrient Intake (beverage)", "type": "OTHER" }, { "name": "Skeletal muscle biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "OTHER", "PROCEDURE" ], "sponsor": "PepsiCo Global R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 26, "start_date": "2018-09-19", "completion_date": "2019-12-21", "has_results": false, "last_update_posted_date": "2021-03-10", "last_synced_at": "2026-10-04T14:21:03.512Z", "location_count": 1, "location_summary": "West Lafayette, Indiana", "locations": [ { "city": "West Lafayette", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04371237" } ] }